North America Vaccines Market (2025-2031) | Investment Trends, Outlook, Competition, Consumer Insights, Revenue, Segments, Competitive, Segmentation, Restraints, Industry, Companies, Drivers, Demand, Growth, Strategic Insights, Opportunities, Pricing Analysis, Size, Strategy, Share, Forecast, Value, Challenges, Analysis, Supply, Trends

Market Forecast by Countries (United States (US), Canada, Rest of North America), By Technology (Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines), By Type (Monovalent vaccines, Multivalent vaccines), By Disease Indication (Pneumococcal disease, DTP, Influenza, HPV, Meningococcal disease, Polio, Rotavirus, Other disease indications), By Route of Administration (Intramuscular and subcutaneous administration, Oral administration, Other routes of administration), By Patient Type (Pediatric patients, Adult patients) And Competitive Landscape
Product Code: ETC13176705 Publication Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 150 No. of Figures: 55 No. of Tables: 32

Key Highlights of the Report:

  • North America Vaccines Market Outlook
  • Market Size of North America Vaccines Market, 2024
  • Forecast of North America Vaccines Market, 2031
  • Historical Data and Forecast of North America Vaccines Revenues & Volume for the Period 2021 - 2031
  • North America Vaccines Market Trend Evolution
  • North America Vaccines Market Drivers and Challenges
  • North America Vaccines Price Trends
  • North America Vaccines Porter's Five Forces
  • North America Vaccines Industry Life Cycle
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
  • Historical Data and Forecast of North America Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
  • Historical Data and Forecast of North America Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
  • North America Vaccines Market - Key Performance Indicators
  • North America Vaccines Market - Import Export Trade Statistics
  • North America Vaccines Market - Opportunity Assessment By Countries
  • North America Vaccines Market - Opportunity Assessment By Technology
  • North America Vaccines Market - Opportunity Assessment By Type
  • North America Vaccines Market - Opportunity Assessment By Disease Indication
  • North America Vaccines Market - Opportunity Assessment By Route of Administration
  • North America Vaccines Market - Opportunity Assessment By Patient Type
  • North America Vaccines Market - Top Companies Market Share
  • North America Vaccines Market - Top Companies Profiles
  • North America Vaccines Market - Comparison of Players in Technical and Operating Parameters
  • North America Vaccines Market - Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the North America Vaccines Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the North America Vaccines Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

North America Vaccines Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 North America Vaccines Market Overview

3.1 North America Regional Macro Economic Indicators

3.2 North America Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 North America Vaccines Market - Industry Life Cycle

3.4 North America Vaccines Market - Porter's Five Forces

3.5 North America Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F

3.6 North America Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 North America Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F

3.8 North America Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.9 North America Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.10 North America Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F

4 North America Vaccines Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 North America Vaccines Market Trends

6 North America Vaccines Market, 2021 - 2031

6.1 North America Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031

6.1.1 Overview & Analysis

6.1.2 North America Vaccines Market, Revenues & Volume, By Conjugate vaccines, 2021 - 2031

6.1.3 North America Vaccines Market, Revenues & Volume, By Inactivated and subunit vaccines, 2021 - 2031

6.1.4 North America Vaccines Market, Revenues & Volume, By Live attenuated vaccines, 2021 - 2031

6.1.5 North America Vaccines Market, Revenues & Volume, By Recombinant vaccines, 2021 - 2031

6.1.6 North America Vaccines Market, Revenues & Volume, By Toxoid vaccines, 2021 - 2031

6.2 North America Vaccines Market, Revenues & Volume, By Type, 2021 - 2031

6.2.1 Overview & Analysis

6.2.2 North America Vaccines Market, Revenues & Volume, By Monovalent vaccines, 2021 - 2031

6.2.3 North America Vaccines Market, Revenues & Volume, By Multivalent vaccines, 2021 - 2031

6.3 North America Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031

6.3.1 Overview & Analysis

6.3.2 North America Vaccines Market, Revenues & Volume, By Pneumococcal disease, 2021 - 2031

6.3.3 North America Vaccines Market, Revenues & Volume, By DTP, 2021 - 2031

6.3.4 North America Vaccines Market, Revenues & Volume, By Influenza, 2021 - 2031

6.3.5 North America Vaccines Market, Revenues & Volume, By HPV, 2021 - 2031

6.3.6 North America Vaccines Market, Revenues & Volume, By Meningococcal disease, 2021 - 2031

6.3.7 North America Vaccines Market, Revenues & Volume, By Polio, 2021 - 2031

6.3.8 North America Vaccines Market, Revenues & Volume, By Rotavirus, 2021 - 2031

6.3.9 North America Vaccines Market, Revenues & Volume, By Other disease indications, 2021 - 2031

6.4 North America Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031

6.4.2 North America Vaccines Market, Revenues & Volume, By Intramuscular and subcutaneous administration, 2021 - 2031

6.4.3 North America Vaccines Market, Revenues & Volume, By Oral administration, 2021 - 2031

6.4.4 North America Vaccines Market, Revenues & Volume, By Other routes of administration, 2021 - 2031

6.5 North America Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031

6.5.1 Overview & Analysis

6.5.2 North America Vaccines Market, Revenues & Volume, By Pediatric patients, 2021 - 2031

6.5.3 North America Vaccines Market, Revenues & Volume, By Adult patients, 2021 - 2031

7 North America Vaccines Market, By Countries, 2021 - 2031

7.1 Overview & Analysis

7.2 North America Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.1 United States (US) Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.2 Canada Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031

7.2.3 Rest of North America Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031

7.3 North America Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F

7.3.1 United States (US) Vaccines Market, Revenues & Volume, By Type, 2021 - 2031

7.3.2 Canada Vaccines Market, Revenues & Volume, By Type, 2021 - 2031

7.3.3 Rest of North America Vaccines Market, Revenues & Volume, By Type, 2021 - 2031

7.4 North America Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031

7.4.1 United States (US) Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031

7.4.2 Canada Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031

7.4.3 Rest of North America Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031

7.5 North America Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.5.1 United States (US) Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.5.2 Canada Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.5.3 Rest of North America Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7.6 North America Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031

7.6.1 United States (US) Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031

7.6.2 Canada Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031

7.6.3 Rest of North America Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031

8 North America Vaccines Market Key Performance Indicators

9 North America Vaccines Market - Export/Import By Countries Assessment

10 North America Vaccines Market - Opportunity Assessment

10.1 North America Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F

10.2 North America Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F

10.3 North America Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F

10.4 North America Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

10.5 North America Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

10.6 North America Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F

11 North America Vaccines Market - Competitive Landscape

11.1 North America Vaccines Market Revenue Share, By Companies, 2022

11.2 North America Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters

12 Top 10 Company Profiles

13 Recommendations

14 Disclaimer

Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All